InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated ...

A new study reveals that dual-atom catalysts behave in a fundamentally different way than scientists previously thought, challenging a long-standing model used to predict catalytic performance.

We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...

A new electrochemical system simultaneously converts plant-derived materials and nitrate pollutants into valuable industrial ...

A groundbreaking superconducting X-ray spectrometer has begun operation at BESSY II, giving Europe its first TES-based system ...

Since the 1980s, researchers have sought to use laser light to control chemical reactions relevant to photochemistry, catalysis and light-responsive materials. But this technique, known as coherent ...

Incyte (Nasdaq:INCY) today reports 2023 second quarter financial results, and provides a status update on the Company's clinical development portfolio. "We delivered ...